191 related articles for article (PubMed ID: 12874768)
1. Plasmablastic transformation of multiple myeloma.
Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
[TBL] [Abstract][Full Text] [Related]
2. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
6. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W
Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627
[TBL] [Abstract][Full Text] [Related]
7. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
[TBL] [Abstract][Full Text] [Related]
8. Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric study.
Shimazaki C; Gotoh H; Oku N; Ashihara E; Inaba T; Murakami S; Ura Y; Nakagawa M; Fujita N
Acta Haematol; 1992; 88(2-3):86-91. PubMed ID: 1466204
[TBL] [Abstract][Full Text] [Related]
9. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
[TBL] [Abstract][Full Text] [Related]
10. Aggressive presentation of plasmablastic myeloma.
Suarez-Londono JA; Rohatgi A; Antoine-Pepeljugoski C; Braunstein MJ
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32265213
[No Abstract] [Full Text] [Related]
11. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
Eladl E; Chang H
Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
[No Abstract] [Full Text] [Related]
13. Imaging flow cytometric detection of del(17p) in bone marrow and circulating plasma cells in multiple myeloma.
Mincherton TI; Lam SJ; Clarke SE; Hui HYL; Malherbe JAJ; Chuah HS; Sidiqi MH; Fuller KA; Erber WN
Int J Lab Hematol; 2024 Jun; 46(3):495-502. PubMed ID: 38379463
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
Moore S; Suttle JM; Nicola M
Methods Mol Biol; 2017; 1541():127-142. PubMed ID: 27910020
[TBL] [Abstract][Full Text] [Related]
15. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
[TBL] [Abstract][Full Text] [Related]
16. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Involvement in Plasma Cell Myeloma.
Panse G; Subtil A; McNiff JM; Glusac EJ; Ko CJ; Galan A; Myung P; Xu ML
Am J Clin Pathol; 2021 Jan; 155(1):106-116. PubMed ID: 32885235
[TBL] [Abstract][Full Text] [Related]
18. Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse.
Martín-Moro F; Roncancio A; Benito A; Talavera M; Villarrubia J; Blanchard MJ
Ann Hematol; 2020 Nov; 99(11):2705-2706. PubMed ID: 32458065
[No Abstract] [Full Text] [Related]
19. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.
Grogan TM
Semin Diagn Pathol; 2003 Aug; 20(3):211-25. PubMed ID: 14552432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
